SCHAUMBURG, Ill., Nov. 2 /PRNewswire-FirstCall/ -- American Pharmaceutical Partners, Inc. today said that the company’s senior management will present a company overview at the CIBC World Markets 16th Annual Healthcare Conference on Tuesday, November 8, at 4:00 p.m. Eastern at the Waldorf-Astoria Hotel in New York.
The presentation will be available to interested parties through a live webcast at APP’s Web site, www.appdrugs.com. Listeners are encouraged to visit the Web site at least 15 minutes prior to the beginning of the scheduled presentation to register, download and install any necessary audio software. For those unable to listen to the live webcast, the presentation will be archived on the same Web site for approximately one month.
About American Pharmaceutical Partners
American Pharmaceutical Partners, Inc. is a specialty drug company that develops, manufactures and markets injectable pharmaceutical products, focusing on the oncology, anti-infective and critical care markets. Abraxis Oncology, the proprietary division of APP, is devoted entirely to developing and promoting innovative, next-generation cancer therapies such as ABRAXANE(TM), recently launched for the treatment of metastatic breast cancer. For more information, visit APP’s website at www.appdrugs.com and www.abraxisoncology.com.
Contacts: American Pharmaceutical Partners, Inc. Nicole Williams Executive Vice President & CFO (847) 969-2700 Robert Jaffe/Rob Whetstone PondelWilkinson Inc. (310) 279-5963
American Pharmaceutical Partners, Inc.
CONTACT: Nicole Williams, Executive Vice President & CFO, AmericanPharmaceutical Partners, Inc., +1-847-969-2700; or Robert Jaffe or RobWhetstone, both of PondelWilkinson Inc., +1-310-279-5963, for AmericanPharmaceutical Partners, Inc.
